Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2023

Open Access 01-12-2023 | Acupuncture | Study Protocol

Acupuncture versus sham acupuncture and usual care for Antiandrogen-Induced hot fLashes in prostate cancer (AVAIL): study protocol for a randomized clinical trial

Authors: Zongshi Qin, Zhiwei Zang, Jianyong Yu, Jianqin Lv, Ning Li, Jialing Zhang, Mingxiao Yang, Joey S. W. Kwong, Ran Pang, Jianfeng Wang, Zhengyu Cui, Yongpei Yu, Haibo Wang, Yidan Zhu, Yifang Yuan, Xiao Li, Yangfeng Wu, Jiani Wu

Published in: BMC Complementary Medicine and Therapies | Issue 1/2023

Login to get access

Abstract

Background

Hot flashes are the common and debilitating symptom among prostate cancer (PCa) patients undergoing androgen deprivation therapy (ADT). Strong evidence from multiple rigorously designed studies indicated that pharmacological option such as venlafaxine provides partial relief, but the tolerability is poor when dose is not tapered. Hence, alternative therapy is needed. Previous studies reported that acupuncture may be helpful in the management of hot flashes. However, the insufficient randomized controlled trial limited the quality of evidence.

Methods

Five hospitals will recruit 120 acupuncture naïve patients with moderate-to-severe hot flashes after prostate cancer received ADT in China from February 2023 to December 2024. Participants will be randomly 2:1:1 allocated to the 18 sessions of verum acupuncture at true acupuncture points plus usual care, 18 sessions of non-penetrating sham acupuncture at non-acupuncture points plus usual care, or usual care alone over 6 weeks. The primary outcome measure is the change of mean weekly hot flashes symptom severity score (HFSSS) at the end of treatment compared with baseline.

Expected Results and Conclusion

We will be able to measure the effectiveness of acupuncture for patients with PCa suffering from ADT-induced hot flashes and whether acupuncture is superior to sham acupuncture and usual care. The proposed acupuncture treatment might provide an alternative option for those patients.

Trial Registration

Clinicaltrials.gov (NCT05069467).
Appendix
Available only for authorised users
Literature
8.
go back to reference Sharifi N, Gulley JL, Dahut WL. Androgen Deprivation Therapy for Prostate Cancer. JAMA. Published online 2005:7. Sharifi N, Gulley JL, Dahut WL. Androgen Deprivation Therapy for Prostate Cancer. JAMA. Published online 2005:7.
9.
go back to reference Irani J, Salomon L, Oba R, Bouchard P, Mottet N. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for Prostate cancer: a double-blind, randomised trial. Lancet Oncol. 2010;11(2):147–54. https://doi.org/10.1016/S1470-2045(09)70338-9.CrossRefPubMed Irani J, Salomon L, Oba R, Bouchard P, Mottet N. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for Prostate cancer: a double-blind, randomised trial. Lancet Oncol. 2010;11(2):147–54. https://​doi.​org/​10.​1016/​S1470-2045(09)70338-9.CrossRefPubMed
20.
go back to reference Miller HG, Li RM. Measuring hot flashes: Summary of a National Institutes of Health Workshop. Mayo Clin Proc. 2004;79:5.CrossRef Miller HG, Li RM. Measuring hot flashes: Summary of a National Institutes of Health Workshop. Mayo Clin Proc. 2004;79:5.CrossRef
Metadata
Title
Acupuncture versus sham acupuncture and usual care for Antiandrogen-Induced hot fLashes in prostate cancer (AVAIL): study protocol for a randomized clinical trial
Authors
Zongshi Qin
Zhiwei Zang
Jianyong Yu
Jianqin Lv
Ning Li
Jialing Zhang
Mingxiao Yang
Joey S. W. Kwong
Ran Pang
Jianfeng Wang
Zhengyu Cui
Yongpei Yu
Haibo Wang
Yidan Zhu
Yifang Yuan
Xiao Li
Yangfeng Wu
Jiani Wu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2023
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-023-04218-y

Other articles of this Issue 1/2023

BMC Complementary Medicine and Therapies 1/2023 Go to the issue